Mustang Bio: Funding, Investors & Team (Sep 2026)
Mustang Bio is a biopharmaceutical company in the clinical stage that concentrates on obtaining, creating, and selling innovative cancer immunotherapy products that aim to harness the patient's immune system to eradicate cancer cells. The products being worked on include CD123, CD20, and CS1.
Mustang Bio has raised $93.9M across 5 funding rounds on record, the most recent an undisclosed round of $8.0M announced in Feb 2025.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Mustang Bio Company Profile and Key Stats
Latest funding round on record: Feb 2025.
Mustang Bio Funding Rounds
Mustang Bio raised $75.0M in a Post-IPO Debt announced in Mar 2022.
1.6 years later, an undisclosed round of $4.4M was announced in Oct 2023.
8 months later, an undisclosed round of $2.5M was announced in Jun 2024.
4 months later, an undisclosed round of $4.0M was announced in Oct 2024.
4 months later, an undisclosed round of $8.0M was announced in Feb 2025.
Mustang Bio Founders and Leadership Team
No contact details are on record for this team yet.
Mustang Bio Funding Compared to Other Biotechnology Startups
Mustang Bio's latest round of $8.0M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Mustang Bio in Biotechnology and New York
Companies Similar to Mustang Bio
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Mustang Bio Funding FAQs
What does Mustang Bio do?
Mustang Bio is a biopharmaceutical company in the clinical stage that concentrates on obtaining, creating, and selling innovative cancer immunotherapy products that aim to harness the patient's immune system to eradicate cancer cells. The products being worked on include CD123, CD20, and CS1.
How much funding has Mustang Bio raised?
Mustang Bio has raised $93.9M across 5 rounds on record. The most recent is an undisclosed round of $8.0M announced in Feb 2025.
When did Mustang Bio last raise funding?
Mustang Bio's most recent funding round on record is an undisclosed round of $8.0M, announced in Feb 2025.
Who founded Mustang Bio?
FundedIQ lists Michael S Weiss Weiss (Founder) at Mustang Bio.
Who is the CEO of Mustang Bio?
Manuel Litchman is listed as CEO at Mustang Bio.
Where is Mustang Bio headquartered?
Mustang Bio is based in New York, United States.
How many employees does Mustang Bio have?
Mustang Bio is in the 51-100 employee band.
How does Mustang Bio's funding compare to other Biotechnology startups?
Mustang Bio's latest round of $8.0M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Mustang Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Mustang Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.